The most common comorbidities were hypertension (54%), diabetes mellitus (28%) and chronic pulmonary disease (25%), 40% of the patients were treated with angiotensin‐converting enzyme inhibitors or angiotensin II receptor blocking drugs (ACEi/ARB) (Table 1). This evidence concerns the gene ACE and hypertensive disorder.